March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Monomeric Wild Type And Constitutively Active Rhodopsin Is Effectively Phosphorylated By Different Grks And Binds Arrestin-1
Author Affiliations & Notes
  • Vsevolod V. Gurevich
    Pharmacology, Vanderbilt University, Nashville, Tennessee
  • Sergey A. Vishnivetskiy
    Pharmacology, Vanderbilt University, Nashville, Tennessee
  • Joerg Standfuss
    Paul Scherrer Institute, Villigen, Switzerland
  • Martin Ostermaier
    Paul Scherrer Institute, Villigen, Switzerland
  • Timothy Bayburt
    University of Illinois, Urbana, Illinois
  • Kristoff T. Homan
    University of Michigan, Ann Arbor, Michigan
  • Alisa Glukhova
    University of Michigan, Ann Arbor, Michigan
  • Stephen G. Sligar
    University of Illinois, Urbana, Illinois
  • John J. Tesmer
    University of Michigan, Ann Arbor, Michigan
  • Gebhard Schertler
    Paul Scherrer Institute, Villigen, Switzerland
  • Footnotes
    Commercial Relationships  Vsevolod V. Gurevich, None; Sergey A. Vishnivetskiy, None; Joerg Standfuss, None; Martin Ostermaier, None; Timothy Bayburt, None; Kristoff T. Homan, None; Alisa Glukhova, None; Stephen G. Sligar, None; John J. Tesmer, None; Gebhard Schertler, None
  • Footnotes
    Support  NIH grants EY011500, GM077561, GM081756 (VVG), HL071818 (JJT), GM033775 (SGS)
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 751. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vsevolod V. Gurevich, Sergey A. Vishnivetskiy, Joerg Standfuss, Martin Ostermaier, Timothy Bayburt, Kristoff T. Homan, Alisa Glukhova, Stephen G. Sligar, John J. Tesmer, Gebhard Schertler; Monomeric Wild Type And Constitutively Active Rhodopsin Is Effectively Phosphorylated By Different Grks And Binds Arrestin-1. Invest. Ophthalmol. Vis. Sci. 2012;53(14):751.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To assess the phosphorylation of monomeric wild type (WT) rhodopsin and constitutively active M257Y mutant by different GRKs and determine relative degree of arrestin binding.

Methods: : Recombinant purified WT and M257Y rhodopsin were reconstituted as monomers into nanodiscs and used for in vitro phosphorylation by purified GRK1, GRK2, and GRK5. The binding of WT arrestin-1 and constitutively active mutants to phosphorylated dark and light-activated (P-Rh*) rhodopsins was measured.

Results: : GRK1, GRK2, and GRK5 transfer 2-3 phosphates per rhodopsin monomer under conditions that yield virtually the same phosphorylation levels of bovine WT rhodopsin in native disc membranes. Thus, for the activation and phosphate transfer GRKs only require the determinants present in a single rhodopsin molecule. High binding of arrestin-1 to P-Rh* does not depend on the GRK that phosphorylated it, showing that all GRKs transfer phosphates to the same or functionally equivalent positions. WT arrestin-1 shows higher binding to dark phosphorylated M257Y than to WT rhodopsin, consistent with constitutive activity of M257Y mutant. Pre-activated arrestin-1-(1-378) and 3A mutants, where the C-tail is deleted or detached from the body of the molecule by triple alanine substitution, demonstrate higher binding to P-Rh* form of both rhodopsins. Moreover, the binding of arrestin-1-3A and (1-378) to dark phosphorylated M257Y reaches ~60% of their binding to P-Rh*, whereas in case of WT rhodopsin it is only ~10% of P-Rh* binding.

Conclusions: : Monomeric WT and mutant rhodopsin is sufficient for effective phosphorylation by all GRKs, demonstrating that GRKs can be effectively activated by monomeric GPCRs. In all cases the phosphorylation promotes high-affinity arrestin-1 binding.

Keywords: protein structure/function • photoreceptors • signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×